Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences
November 05 2020 - 8:00AM
Business Wire
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine
company, announced today that management will present at the
following investor conferences:
- 29th Annual Credit Suisse Virtual Healthcare Conference
Presentation Date: Monday, November 9th at 5 p.m. Eastern Time
- Barclays Gene Editing & Gene Therapy Summit
Presentation Date: Monday, November 16th at 10:45 a.m. Eastern
Time
Presentations will be webcast live and may be accessed via a
link on the Sangamo Therapeutics website in the Investors and Media
section under Events and Presentations. The presentation will also
be available on the Sangamo website after the event.
About Sangamo Therapeutics
Sangamo Therapeutics is committed to translating ground-breaking
science into genomic medicines with the potential to transform
patients’ lives using gene therapy, ex vivo gene-edited cell
therapy, and in vivo genome editing and genome regulation. For more
information about Sangamo, visit www.sangamo.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20201105005222/en/
Investor Relations & Media
Inquiries Aron Feingold 628.252.7494
afeingold@sangamo.com
Sangamo Therapeutics (NASDAQ:SGMO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Sangamo Therapeutics (NASDAQ:SGMO)
Historical Stock Chart
From Sep 2023 to Sep 2024